{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:47:24Z","timestamp":1787028444460,"version":"build-2736575974"},"reference-count":103,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Platinum-based chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common dose-limiting effects of cancer treatment and results in dose reduction and discontinuation of life-saving chemotherapy. Its debilitating effects are often permanent and lead to lifelong impairment of quality of life in cancer patients. While the mechanisms underlying the toxicity are not yet fully defined, dorsal root ganglia sensory neurons play an integral role in symptom development. DNA-platinum adducts accumulate in these cells and inhibit normal cellular function. Nucleotide excision repair (NER) is integral to the repair of platinum adducts, and proteins involved in its mechanism serve as potential targets for future therapeutics. This review aims to highlight NER\u2019s role in cisplatin-induced peripheral neuropathy, summarize current clinical approaches to the toxicity, and discuss future perspectives for the prevention and treatment of CIPN.<\/jats:p>","DOI":"10.3390\/ijms22041975","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T21:35:42Z","timestamp":1613597742000},"page":"1975","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-6225","authenticated-orcid":false,"given":"Scarlett","family":"Acklin","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1517\/14740338.2011.543417","article-title":"Chemotherapy-induced peripheral neuropathies: From clinical relevance to preclinical evidence","volume":"10","author":"Balayssac","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/S12094-010-0474-z","article-title":"Chemotherapy-induced peripheral neuropathy: Clinical features, diagnosis, prevention and treatment strategies","volume":"12","author":"Sereno","year":"2010","journal-title":"Clin. Transl. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s11910-017-0757-7","article-title":"Update on Chemotherapy-Induced Peripheral Neuropathy","volume":"17","author":"Cioroiu","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1566-0702(00)00247-2","article-title":"Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by Cisplatin: Behavioral, structural and biochemical analysis","volume":"86","author":"Aloe","year":"2000","journal-title":"Auton. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02341156","article-title":"Cisplatin induced neuropathy: Central, peripheral and autonomic nerve involvement","volume":"9","author":"Boogerd","year":"1990","journal-title":"J. Neuro-Oncol."},{"key":"ref_6","first-page":"1","article-title":"Lhermitte\u2019s Phenomenon and Platinum, Beware of Latency","volume":"37","author":"Ryan","year":"2014","journal-title":"Oncol. Res. Treat."},{"key":"ref_7","first-page":"1","article-title":"Prevalence and Predictors of Cisplatin-Induced Peripheral Neuropathy at the Kenyatta National Hospital","volume":"5","author":"Ezzi","year":"2019","journal-title":"J. Glob. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): An update","volume":"82","author":"Argyriou","year":"2012","journal-title":"Crit. Rev. Oncol."},{"key":"ref_9","first-page":"151","article-title":"Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy","volume":"72","author":"Cata","year":"2006","journal-title":"Minerva Anestesiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fphar.2013.00156","article-title":"Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)","volume":"4","author":"Han","year":"2013","journal-title":"Front. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.clinph.2017.04.009","article-title":"Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer","volume":"128","author":"Kandula","year":"2017","journal-title":"Clin. Neurophysiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4103\/1673-5374.276321","article-title":"Insights into platinum-induced peripheral neuropathy\u2013current perspective","volume":"15","author":"Lazic","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/1871520611313020016","article-title":"Platinum Compounds: A Hope for Future Cancer Chemotherapy","volume":"13","author":"Ali","year":"2013","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/nar\/gkz1101","article-title":"Multiple roles of DNA2 nuclease\/helicase in DNA metabolism, genome stability and human diseases","volume":"48","author":"Zheng","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","article-title":"The rediscovery of platinum-based cancer therapy","volume":"21","author":"Rottenberg","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nickoloff, J.A., Jones, D., Lee, S.-H., Williamson, E.A., and Hromas, R. (2017). Drugging the Cancers Addicted to DNA Repair. J. Natl. Cancer Inst., 109.","DOI":"10.1093\/jnci\/djx059"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuro.2006.04.010","article-title":"Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum\u2013DNA binding","volume":"27","author":"Ta","year":"2006","journal-title":"NeuroToxicology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/14728222.2017.1328057","article-title":"Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain","volume":"21","author":"Berta","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1227\/NEU.0000000000001255","article-title":"The Dorsal Root Ganglion in the Pathogenesis of Chronic Neuropathic Pain","volume":"63","author":"Guha","year":"2016","journal-title":"Neurosurgery"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbi.2017.10.011","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2) dependent microglial activation promotes cisplatin-induced peripheral neuropathy in mice","volume":"68","author":"Hu","year":"2018","journal-title":"Brain, Behav. Immun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41598-017-05784-1","article-title":"Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms","volume":"7","author":"Imai","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fphar.2017.00086","article-title":"Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review","volume":"8","author":"Kerckhove","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/toxics3020198","article-title":"Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)","volume":"3","author":"Canta","year":"2015","journal-title":"Toxics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/jcb.25103","article-title":"Base Excision Repair in the Mitochondria","volume":"116","author":"Prakash","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389200219666171207121313","article-title":"Role of Mitochondrial Mechanism in Chemotherapy-Induced Peripheral Neuropathy","volume":"19","author":"Waseem","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1744806917746565","DOI":"10.1177\/1744806917746565","article-title":"Cisplatin alters the function and expression of N-type voltage-gated calcium channels in the absence of morphological damage of sensory neurons","volume":"13","author":"Leo","year":"2017","journal-title":"Mol. Pain"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2016.11.003","article-title":"Cisplatin-induced neuropathic pain is mediated by upregulation of N-type voltage-gated calcium channels in dorsal root ganglion neurons","volume":"288","author":"Leo","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.29367","article-title":"PKC\/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects","volume":"137","author":"Tsubaki","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuropharm.2018.07.026","article-title":"Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin","volume":"140","author":"Poupon","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5306\/wjco.v8.i4.329","article-title":"Platinum-induced neurotoxicity: A review of possible mechanisms","volume":"8","author":"Ozkan","year":"2017","journal-title":"World J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zaj\u0105czkowska, R., Kocot-K\u0119pska, M., Leppert, W., Wrzosek, A., Mika, J., and Wordliczek, J. (2019). Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061451"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.12.006","article-title":"Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy","volume":"73","author":"Lees","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00424-015-1766-5","article-title":"VRAC: Molecular identification as LRRC8 heteromers with differential functions","volume":"468","author":"Jentsch","year":"2015","journal-title":"Pfl\u00fcgers Archiv Eur. J. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.bpj.2019.02.014","article-title":"Biophysics and Structure-Function Relationships of LRRC8-Formed Volume-Regulated Anion Channels","volume":"116","author":"Stauber","year":"2019","journal-title":"Biophys. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.15252\/embj.201592409","article-title":"Subunit composition of VRAC channels determines substrate specificity and cellular resistance to P t-based anti-cancer drugs","volume":"34","author":"Lutter","year":"2015","journal-title":"EMBO J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fnins.2020.00287","article-title":"Chloride\u2014The Underrated Ion in Nociceptors","volume":"14","author":"Wilke","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/cts.12480","article-title":"Identification of OAT1\/OAT3 as Contributors to Cisplatin Toxicity","volume":"10","author":"Hu","year":"2017","journal-title":"Clin. Transl. Sci."},{"key":"ref_38","first-page":"1459","article-title":"New Insight of OCT2 Regulation as Mediator for Cisplatin- Induced Nephrotoxicity","volume":"18","author":"Abdalla","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.phrs.2016.11.023","article-title":"Dual function of OCT2 and MATE1 in cisplatin induced nephrotoxicity","volume":"119","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1305321110","article-title":"Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2","volume":"110","author":"Sprowl","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1172\/JCI136796","article-title":"Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice","volume":"130","author":"Huang","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_42","first-page":"483","article-title":"Neuronal drug transporters in platinum drugs-induced peripheral neurotoxicity","volume":"34","author":"Cavaletti","year":"2014","journal-title":"Anticancer. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00280-009-1017-6","article-title":"Neuronal expression of copper transporter 1 in rat dorsal root ganglia: Association with platinum neurotoxicity","volume":"64","author":"Liu","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e1257","DOI":"10.1038\/cddis.2013.428","article-title":"Systems biology of cisplatin resistance: Past, present and future","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_45","first-page":"1663","article-title":"Cisplatin and platinum drugs at the molecular level. (Review)","volume":"10","author":"Boulikas","year":"2003","journal-title":"Oncol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.dnarep.2013.04.020","article-title":"DNA damage response in peripheral nervous system: Coping with cancer therapy-induced DNA lesions","volume":"12","author":"Englander","year":"2013","journal-title":"DNA Repair"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nbd.2004.09.013","article-title":"Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: A potential mechanism for neurotoxicity","volume":"18","author":"McDonald","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopha.2018.01.080","article-title":"Forskolin protects against cisplatin-induced ototoxicity by inhibiting apoptosis and ROS production","volume":"99","author":"Guo","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fnmol.2017.00108","article-title":"Inhibition of Mitochondrial p53 Accumulation by PFT-\u03bc Prevents Cisplatin-Induced Peripheral Neuropathy","volume":"10","author":"Maj","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.nbd.2010.11.017","article-title":"Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons","volume":"41","author":"Podratz","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"ref_51","first-page":"233","article-title":"Mechanisms of Mitochondrial DNA Repair in Mammals","volume":"83","author":"Zinovkina","year":"2018","journal-title":"Biochemistry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1523\/JNEUROSCI.0523-07.2007","article-title":"Repair Capacity for Platinum-DNA Adducts Determines the Severity of Cisplatin-Induced Peripheral Neuropathy","volume":"27","author":"Dzagnidze","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_53","first-page":"4899","article-title":"Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells","volume":"62","author":"Furuta","year":"2002","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ijc.20134","article-title":"Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines","volume":"110","author":"Welsh","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1101\/sqb.2000.65.173","article-title":"DNA Damage Recognition and Nucleotide Excision Repair in Mammalian Cells","volume":"65","author":"Wood","year":"2000","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1089\/ars.2013.5492","article-title":"Human Apurinic\/Apyrimidinic Endonuclease 1","volume":"20","author":"Li","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.dnarep.2018.08.012","article-title":"APE1: A skilled nucleic acid surgeon","volume":"71","author":"Whitaker","year":"2018","journal-title":"DNA Repair"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.dnarep.2009.08.003","article-title":"Role of APE1 in differentiated neuroblastoma SH-SY5Y cells in response to oxidative stress: Use of APE1 small molecule inhibitors to delineate APE1 functions","volume":"8","author":"Jiang","year":"2009","journal-title":"DNA Repair"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mrfmmm.2015.06.010","article-title":"APE1, the DNA base excision repair protein, regulates the removal of platinum adducts in sensory neuronal cultures by NER","volume":"779","author":"Kim","year":"2015","journal-title":"Mutat. Res. Mol. Mech. Mutagen."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s12035-017-0507-5","article-title":"Translesion Synthesis DNA Polymerase Kappa Is Indispensable for DNA Repair Synthesis in Cisplatin Exposed Dorsal Root Ganglion Neurons","volume":"55","author":"Zhuo","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1093\/nar\/gku913","article-title":"The Werner syndrome protein limits the error-prone 8-oxo-dG lesion bypass activity of human DNA polymerase kappa","volume":"42","author":"Maddukuri","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dnarep.2013.02.008","article-title":"Mouse DNA polymerase kappa has a functional role in the repair of DNA strand breaks","volume":"12","author":"Zhang","year":"2013","journal-title":"DNA Repair"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ncb1417","article-title":"The Y-family DNA polymerase \u03ba (pol \u03ba) functions in mammalian nucleotide-excision repair","volume":"8","author":"Ogi","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.molcel.2010.02.009","article-title":"Three DNA Polymerases, Recruited by Different Mechanisms, Carry Out NER Repair Synthesis in Human Cells","volume":"37","author":"Ogi","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"eabb2934","DOI":"10.1126\/scisignal.abb2934","article-title":"DNA polymerase \u03ba: Friend or foe?","volume":"13","author":"Sweasy","year":"2020","journal-title":"Sci. Signal."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.dnarep.2016.05.018","article-title":"XPA: A key scaffold for human nucleotide excision repair","volume":"44","author":"Sugitani","year":"2016","journal-title":"DNA Repair"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Duan, M., Ulibarri, J., Liu, K.J., and Mao, P. (2020). Role of Nucleotide Excision Repair in Cisplatin Resistance. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239248"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/bjc.2016.311","article-title":"PARP inhibitors for BRCA1\/2-mutated and sporadic ovarian cancer: Current practice and future directions","volume":"115","author":"Konecny","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"102850","DOI":"10.1016\/j.dnarep.2020.102850","article-title":"Requirements for PARP-1 covalent crosslinking to DNA (PARP-1 DPC)","volume":"90","author":"Prasad","year":"2020","journal-title":"DNA Repair"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"39824","DOI":"10.1074\/jbc.M112.393504","article-title":"Poly(ADP-ribose) Contributes to an Association between Poly(ADP-ribose) Polymerase-1 and Xeroderma Pigmentosum Complementation Group A in Nucleotide Excision Repair","volume":"287","author":"King","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1083\/jcb.201112132","article-title":"PARP1 promotes nucleotide excision repair through DDB2 stabilization and recruitment of ALC1","volume":"199","author":"Pines","year":"2012","journal-title":"J. Cell Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"E6847","DOI":"10.1073\/pnas.1706981114","article-title":"Poly(ADP-ribose) polymerase 1 escorts XPC to UV-induced DNA lesions during nucleotide excision repair","volume":"114","author":"Robu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.lungcan.2013.01.014","article-title":"PARP1 impact on DNA repair of platinum adducts: Preclinical and clinical read-outs","volume":"80","author":"Olaussen","year":"2013","journal-title":"Lung Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fphar.2012.00029","article-title":"Regulation of Sirtuin Function by Posttranslational Modifications","volume":"3","author":"Flick","year":"2012","journal-title":"Front. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jmb.2013.10.027","article-title":"Constitutive Nuclear Localization of an Alternatively Spliced Sirtuin-2 Isoform","volume":"426","author":"Rack","year":"2014","journal-title":"J. Mol. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1021\/acs.biochem.7b00859","article-title":"Resveratrol Exerts Antioxidant Effects by Activating SIRT2 To Deacetylate Prx1","volume":"56","author":"Pan","year":"2017","journal-title":"Biochemistry"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1038\/ncomms12948","article-title":"Nicotinamide riboside is uniquely and orally bioavailable in mice and humans","volume":"7","author":"Trammell","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"26933","DOI":"10.1038\/srep26933","article-title":"Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice","volume":"6","author":"Trammell","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"117350","DOI":"10.1016\/j.lfs.2020.117350","article-title":"Attenuation of diabetic retinopathy and neuropathy by resveratrol: Review on its molecular mechanisms of action","volume":"245","author":"Ahmad","year":"2020","journal-title":"Life Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00520-015-2876-5","article-title":"MC11C4: A pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy","volume":"24","author":"Zimmerman","year":"2016","journal-title":"Support. Care Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1634\/theoncologist.2017-0235","article-title":"Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind Trial","volume":"22","author":"Teixeira","year":"2017","journal-title":"Oncologist"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00520-017-4028-6","article-title":"Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","volume":"26","author":"Kuriyama","year":"2018","journal-title":"Support. Care Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00520-016-3404-y","article-title":"A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN)","volume":"25","author":"Schloss","year":"2016","journal-title":"Support. Care Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00520-013-2075-1","article-title":"Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled trial","volume":"22","author":"Guo","year":"2014","journal-title":"Support. Care Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/0284186X.2017.1398836","article-title":"Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx\u00ae): A placebo-controlled randomised phase II study (PLIANT)","volume":"57","author":"Glimelius","year":"2017","journal-title":"Acta Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.taap.2018.12.015","article-title":"L-Carnosine protects against Oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: A perspective on targeting Nrf-2 and NF-\u03baB pathways","volume":"365","author":"Yehia","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00384-018-3104-9","article-title":"Role of metformin in oxaliplatin-induced peripheral neuropathy in patients with stage III colorectal cancer: Randomized, controlled study","volume":"33","author":"Ibrahim","year":"2018","journal-title":"Int. J. Color. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00520-017-4013-0","article-title":"Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: A multicenter, randomized controlled trial","volume":"26","author":"Kleckner","year":"2017","journal-title":"Support. Care Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0825859719827589","article-title":"A Pilot Randomized Sham-Controlled Trial of MC5-A Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)","volume":"35","author":"Smith","year":"2020","journal-title":"J. Palliat. Care"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00520-019-04881-3","article-title":"Scrambler therapy for chemotherapy neuropathy: A randomized phase II pilot trial","volume":"28","author":"Loprinzi","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1534735419836501","DOI":"10.1177\/1534735419836501","article-title":"A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy","volume":"18","author":"Molassiotis","year":"2019","journal-title":"Integr. Cancer Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00280-018-3664-y","article-title":"Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy","volume":"82","author":"Farshchian","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_94","unstructured":"(2021, January 02). Duloxetine: Drug Information. Available online: https:\/\/www.uptodate.com\/contents\/duloxetine-drug-information?search=duloxetine&source=panel_search_result&selectedTitle=1~103&usage_type=panel&kp_tab=drug_general&display_rank=1#references."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00520-017-3875-5","article-title":"Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: A randomized controlled trial","volume":"26","author":"Zimmer","year":"2017","journal-title":"Support. Care Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/bjc.2014.466","article-title":"Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy","volume":"111","author":"Courneya","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"D\u2019Alessandro, E.G., Nagy, D.R.N., De Brito, C.M.M., Almeida, E.P.M., Battistella, L.R., and Cecatto, R.B. (2019). Acupuncture for chemotherapy-induced peripheral neuropathy: A randomised controlled pilot study. BMJ Support. Palliat. Care.","DOI":"10.1136\/bmjspcare-2018-001542"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/rej.2016.1883","article-title":"Antiaging Effect of Metformin on Brain in Naturally Aged and Accelerated Senescence Model of Rat","volume":"20","author":"Garg","year":"2017","journal-title":"Rejuvenation Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"110647","DOI":"10.1016\/j.exger.2019.110647","article-title":"The balance of apoptosis and autophagy via regulation of the AMPK signal pathway in aging rat striatum during regular aerobic exercise","volume":"124","author":"Liu","year":"2019","journal-title":"Exp. Gerontol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.117.028728","article-title":"SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy","volume":"136","author":"Tang","year":"2017","journal-title":"Circulation"},{"key":"ref_101","first-page":"249013","article-title":"Acupuncture May Exert Its Therapeutic Effect through MicroRNA-339\/Sirt2\/NF\u03baB\/FOXO1 Axis","volume":"2015","author":"Wang","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/j.pain.0000000000000862","article-title":"Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats","volume":"158","author":"Hamity","year":"2017","journal-title":"Pain"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/1975\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:25:10Z","timestamp":1760160310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/1975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":103,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijms22041975"],"URL":"https:\/\/doi.org\/10.3390\/ijms22041975","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]}}}